Want to join the conversation?
John Kreger of William Blair asks for an update on SIMPARICA. $ZTS said it expects SIMPARICA to be a key product in its portfolio and believes it will be an important platform to add new products into the parasiticide franchise. $ZTS expects this product to generate more than $100MM. Current market trends show a higher opportunity for SIMPARICA.
I haven’t seen a drop in banks like this in a long time. Looks like $WFC is still facing pressures from its sales practices scandal..!!
Helping President-elect's America first focus, $WMT set to create 10,000 retail jobs in the US in 2017.
Looks like Trump has his eyes on the $MON and Bayer merger next. He had a meeting with the CEOs and apparently got job promises from them.